Navigation Links
Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
Date:11/10/2008

d, that third parties on whom we depend will perform as anticipated, or that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our ability to successfully accelerate the commercialization of our therapeutic hypothermia devices and launch new devices within the timeframes contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit http://www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(TM) are trademarks of Cardium
Therapeutics, Inc. Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM)

are trademarks of Tissue Repair Company. InnerCool Therapies(R), InnerCool(R), Celsius Control System(R),

RapidBlue(TM
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
2. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
3. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
4. Cardium Announces Follow-On Direct Investment by Institutional Investor
5. Cardium Selected for Inclusion in Russell Microcap Index
6. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
7. Cardium Launches New AWARE Clinical Study Website
8. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Cardium Reports on First Quarter 2008 Highlights and Financial Results
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... 2015 An increase of awareness related ... forms of food nutrients, regulatory changes and concerns related ... in demand for natural astaxanthin over the past few ... up their capacities to satisfy the rising demand. ... source astaxanthin (used in nutraceuticals, aqua feed, food and ...
(Date:3/25/2015)... Having added two International locations in Brisbane ... ITRA Global proudly announced recently the organization’s expansion into ... based in the United States, is one of the ... commercial real estate. , Saltwood International is ... exclusively advises occupiers of office space, ensuring that its ...
(Date:3/25/2015)... ATLANTA , March 25, 2015  The Technology ... state,s leading association dedicated to the promotion and economic ... today announced Streamline Health as one of its Top ... . TAG will recognize this prestigious group at the ... at the Cobb Galleria Centre. TAG,S Top ...
(Date:3/25/2015)... 25, 2015 FDNA®, the pioneer ... of Face2Gene, allowing geneticists around the globe ... well as mobile devices. Face2Gene® facilitates detection of facial ... present comprehensive and up-to-date genetic references. The date of ... ACMG 2015, in Salt Lake City, UT ...
Breaking Biology Technology:Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2International Organization Expands its Global Reach to Warsaw, Poland 2Streamline Health, Inc. Named a TAG Top 40 Innovative Technology Company 2Streamline Health, Inc. Named a TAG Top 40 Innovative Technology Company 3Streamline Health, Inc. Named a TAG Top 40 Innovative Technology Company 4FDNA Releases a Multi-Platform Version of Face2Gene, a Genetic Search and Reference Solution at ACMG 2015 2
... NanoBio(R) Corp., a,biopharmaceutical company focused on developing and ... today announced the,appointment of Daniel B. Dubin, M.D., ... currently serves as Vice Chairman and a Director ... banking firm., "Dan,s keen understanding of the ...
... July 8 Knowledge Enterprises, Inc.,and The ... of The,2007-2008 Orthopaedic Industry Annual Report, the ... data. The nearly 200,page Annual Report summarizes ... Joint Replacement, Fracture Repair, Arthroscopy/Soft,Tissue Repair, Spinal ...
... PALO ALTO, Calif., July 8 Telik, Inc.,(Nasdaq: ... research in Bioorganic &,Medicinal Chemistry Letters describing a ... lead to a new treatment for diabetes.,These unique ... chemistry,effort at Telik to optimize the original lead ...
Cached Biology Technology:Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors 2Knowledge Enterprises, Inc. and The Institute for Orthopaedics(TM) Release The 2007-2008 Orthopaedic Industry Annual Report 2Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters 2
(Date:3/24/2015)... ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of the ... report to their offering. This report analyzes the worldwide ... following Segments: Face Biometrics, and Voice Biometrics. The report provides separate ... Japan , Europe , ... Africa , and Latin America . ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... fly Drosophila melanogaster quite an attractive "model," but not ... is a biomedical research model that can reveal the ... humans, because we share the basic biochemical machinery of ... the molecular, genetic, cellular and physiological responses of whole ...
... Natalia Martin, Ph.D. , is The Pew Charitable Trusts, ... on neuroimmunology. Martin studies the role of the nervous ... body,s first line of defense against invading pathogens. ... Ph.D., at Duke University, Martin uses techniques from neurology ...
... a number of pathological conditions, including cancer. Publishing in ... drinking water given at the maximum levels permitted in ... mice. On the other hand, reducing copper levels reduced tumor ... factor for the growth of tumors in humans as well. ...
Cached Biology News:NASA's next 'top model,' the fruit fly 2NASA's next 'top model,' the fruit fly 3Immunity studies cross scientific and continental borders (video) 2Copper intake makes tumors breathe 2
... Combination inline heater plus multi-channel focal ... drug wash-out with a high-flow bath line ... solutions through the Perfusion Pencil.® Steady 37°C ... the bath line and tip. ...
Mouse monoclonal [ICRF 44] to Integrin alpha M...
Mouse Amphiregulin MAb (Clone 206220)...
Request Info...
Biology Products: